During the past decade, Nuovo Ospedale Civile di Sassuolo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nuovo Ospedale Civile di Sassuolo" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 2 trials, followed by "Gruppo di Ricerca GISSI" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Fadoi Foundation, Italy" with 1 trials sponsored and "Società Italiana di Cardiologia Invasiva" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nuovo Ospedale Civile di Sassuolo" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Royal Brompton & Harefield NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nuovo Ospedale Civile di Sassuolo" are "Atrial Fibrillation" (2 trials), "Diffuse Large B-Cell" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Heart Failure" (1 trials) and "Invasive Candidiasis" (1 trials). Many other conditions were trialed in "Nuovo Ospedale Civile di Sassuolo" in a lesser frequency.

Most popular intervention types in "Nuovo Ospedale Civile di Sassuolo" are "Drug" (5 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "1,3-β-D-glucan quantification" (1 trials), "Bendamustine+Rituximab" (1 trials), "Coronary Angioplasty (PTCA)" (1 trials) and "Micafungin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nuovo Ospedale Civile di Sassuolo" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Nuovo Ospedale Civile di Sassuolo". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nuovo Ospedale Civile di Sassuolo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nuovo Ospedale Civile di Sassuolo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Nuovo Ospedale Civile di Sassuolo has several departments that took part in Clinical trials: "Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico" - 7 trials, "Ospedale Di Sassuolo - Cardiologia" - 5 trials, "UOC Medicina Interna MO DH Oncologico" - 2 trials